Personal Information
Jiaxin Xie

Department of Preventive Medicine, NCOs School of Army Medical University, Shijiazhuang, Hebei, China

Jiaxin Xie
From 09/2007 to 06/2012, Master' Degree and Doctoral Degree , China
From 09/2002 to 06/2007, Bachelor' Degree , China
Work Experiences
From 12/2017 to now, Associate Professor , Army Medical University, China
From 08/2012 to 11/2017, Lecturer , Bethune Medical NCOs School, China
From 01/2015 to 12/2017, Association of estrogen receptor gene polymorphisms with HBV-positive hepatocellular carcinoma , To explore ER gene polymorphisms associated with hepatocellular carcinoma to provide clues for etiological prevention of HBV related HCC
From 01/2011 to 12/2014, Molecular epidemiology of hepatitis B and hepatocellular carcinoma , To investigate the relationship between HBV infection and HCC at molecular level. The project will help clarify the carcinogenic mechanism of HBV infection and explore corresponding prevention and control measures for HCC
Health Statistics
Journal Articles
Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.Hepatology. 2013 Jun;57(6):2369-77. doi: 10.1002/hep.26303. Xie J, Zhang Y, Zhang Q, Han Y, Yin J, Pu R, Shen Q, Lu W, Du Y, Zhao J, Han X, Zhang H, Cao G.
Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol. 2011 Jan;106(1):81-92. Yin J, Xie J, Liu S, Zhang H, Han L, Lu W, Shen Q, Xu G, Dong H, Shen J, Zhang J, Han J, Wang L, Liu Y, Wang F, Zhao J, Zhang Q, Ni W, Wang H, Cao G.
Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol. 2010 Oct;45(10):1063-71. Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W, Wang H, Cao G.
A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma. J Med Virol. 2011 Jan;83(1):45-53. Liu S, Xie J, Yin J, Zhang H, Zhang Q, Pu R, Li C, Ni W, Wang H, Cao G.
Association of novel mutations and haplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma. Front Med China. 2010 Dec;4(4):419-29. Xie JX, Zhao J, Yin JH, Zhang Q, Pu R, Lu WY, Zhang HW, Wang HY, Cao GW.
Interaction effects among IFN-γ+874, IL-2-330, IL-10-1082, IL-10-592 and IL-4-589 polymorphisms on the clinical progression of subjects infected with hepatitis B virus and/or hepatitis C virus: a retrospective nested case-control study. BMJ Open. 2017 Aug 23;7(8):e013279. Gao QJ, Xie JX, Wang LM, Zhou Q, Zhang SY.
Genome-wide association studies: inherent limitations and future challenges. Front Med. 2012 Dec;6(4):444-50. Du Y, Xie J, Chang W, Han Y, Cao G.
Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst. 2009 Aug 5;101(15):1066-82. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G.
Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):777-86. Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W, Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G.
IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis. 2009 Nov;30(11):1916-22. He Y, Zhang H, Yin J, Xie J, Tan X, Liu S, Zhang Q, Li C, Zhao J, Wang H, Cao G.
A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol. 2011 Oct 14;17(38):4321-33. Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW.
Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS One. 2013;8(3):e58564. Han Y, Pu R, Han X, Zhao J, Zhang Y, Zhang Q, Yin J, Xie J, Shen Q, Deng Y, Ding Y, Li W, Li J, Zhang H, Cao G.
HBV genotype C is independently associated with cirrhosis in community-based population. World J Gastroenterol. 2010 Jan 21;16(3):379-83. Yin JH, Zhao J, Zhang HW, Xie JX, Li WP, Xu GZ, Shen J, Dong HJ, Zhang J, Wang L, Han JK, Wang HY, Cao GW.
Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study. Cancer Epidemiol. 2012 Apr;36(2):177-82. Wang G, Hou J, Ma L, Xie J, Yin J, Xu D, Chang W, Tan X, Su T, Zhang H, Cao G.
Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Liver Int. 2014 May;34(5):728-36. Han Y, Pu R, Han X, Zhao J, Li W, Yin J, Zhang Y, Shen Q, Xie J, Zhang Q, Jiang S, Li J, Zhang H, Wang H, Cao G.
Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma. Gene. 2013 Jan 1;512(1):64-9. Du Y, Su T, Tan X, Li X, Xie J, Wang G, Shen J, Hou J, Cao G.
Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Front Med. 2014 Jun;8(2):217-26. Du Y, Han X, Pu R, Xie J, Zhang Y, Cao G.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186